# MYOD1

Source: https://onco.cc/targets/myod1/  
OnCo record `myod1` (Target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

MYOD1 (Myoblast determination protein 1) is a protein that switches other genes on and off. The public catalogues list it as a biomarker, and clinical evidence ties its variants to diagnosis, prognosis or drug response. Tied to Sarcomas, Colorectal cancer and Rhabdomyosarcoma.

## Summary

Acts as a transcriptional activator that promotes transcription of muscle-specific target genes and plays a role in muscle differentiation. Together with MYF5 and MYOG, co-occupies muscle-specific gene promoter core region during myogenesis. Induces fibroblasts to differentiate into myoblasts.

CIViC holds 11 clinical evidence items and 1 assertion across 1 variant. Open Targets scores its association with cancer at 0.69 (direct and indirect evidence; datatypes literature 0.87, affected pathway 0.43, genetic association 0.35, somatic mutation 0.97).

## Fields

- Kind: Target
- Last checked: 2026-09-23
- Also known as: myogenic differentiation 1; Myoblast determination protein 1; bHLHc1; MYF3
- Tags: cancer-genes-wave
- Symbol: MYOD1
- Class: transcription
- Biology: Acts as a transcriptional activator that promotes transcription of muscle-specific target genes and plays a role in muscle differentiation. Together with MYF5 and MYOG, co-occupies muscle-specific gene promoter core region during myogenesis. Induces fibroblasts to differentiate into myoblasts. Interacts with and is inhibited by the twist protein. This interaction probably involves the basic domains of both proteins. Location: Nucleus (UniProt). Locus 11p15.1 (HGNC).
- Where found: Sarcomas: Open Targets association 0.60 with sarcoma (MONDO_0005089); Colorectal cancer: Open Targets association 0.53 with colorectal cancer (MONDO_0005575); Rhabdomyosarcoma: Open Targets association 0.57 with rhabdomyosarcoma (MONDO_0005212); CIViC evidence names this disease

## Notes

- Written by scripts/fetch-cancer-genes.ts from CIViC, Open Targets, IntOGen, HGNC and UniProt; the function text is UniProt's, condensed and in UK spelling. Roles: CIViC holds 11 clinical evidence items on its variants. Evidence tier "clinical-evidence" is the strongest of those signals.
- Prevalence not recorded: none of the sources gives a positivity rate.
- Diseases the sources name that have no OnCo cancer page yet, so they are not linked: Spindle Cell Rhabdomyosarcoma.

## Sources

- HGNC HGNC:7611: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:7611
- UniProt P15172: https://www.uniprot.org/uniprotkb/P15172/entry
- NCBI Gene 4654: https://www.ncbi.nlm.nih.gov/gene/4654
- Ensembl ENSG00000129152: https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000129152

## Connected records

- collections: [CIViC](https://onco.cc/collections/civic/), [Open Targets Platform](https://onco.cc/collections/open-targets/)
- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Rhabdomyosarcoma](https://onco.cc/cancers/rhabdomyosarcoma/), [Sarcomas (soft tissue, bone, GIST)](https://onco.cc/cancers/sarcoma/)

---
JSON: https://onco.cc/api/v1/entities/myod1.json